4-Deoxy-4-fluoro-D-glucose (CAS 29218-07-3)

4-Deoxy-4-fluoro-D-glucose, a modified form of glucose with a fluorine atom replacing the hydroxyl group at the C-4 position, serves as a valuable tool in biochemical and metabolic research. Its structural similarity to glucose enables its utilization as a metabolic tracer in various experimental settings. One of the primary research applications of this compound involves its incorporation into cellular metabolic pathways to study glucose metabolism and its impact on cellular functions. Researchers employ 4-Deoxy-4-fluoro-D-glucose in positron emission tomography (PET) imaging studies to investigate glucose uptake and utilization in tissues and organs. By radiolabeling this compound with a positron-emitting isotope such as fluorine-18, scientists can visualize and quantify glucose metabolism in vivo, providing insights into the metabolic activity of healthy and diseased tissues. Additionally, 4-Deoxy-4-fluoro-D-glucose finds applications in elucidating the mechanisms underlying metabolic diseases such as diabetes and cancer. Studies utilizing this compound aim to uncover aberrations in glucose metabolism associated with disease progression and identify potential targets for intervention. Furthermore, its use as a metabolic probe facilitates the development of novel diagnostic tools and strategies for managing metabolic disorders. Through continued research efforts, 4-Deoxy-4-fluoro-D-glucose contributes to advancing our understanding of glucose metabolism and its implications for health and disease.